Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 142

Results For "ABI"

3125 News Found

Unimed to expand operations into Singapore with Marine Pharma merger
News | June 06, 2023

Unimed to expand operations into Singapore with Marine Pharma merger

Establishes distribution center in top hub for international shipping


Dr. Reddy's completes Phase I study (IV route) of a proposed biosimilar of tocilizumabp
News | June 06, 2023

Dr. Reddy's completes Phase I study (IV route) of a proposed biosimilar of tocilizumabp

The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable


DIC invests in US-based biotech startup
Startup | June 05, 2023

DIC invests in US-based biotech startup

Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes


International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya
Policy | June 04, 2023

International cooperation must to advance vaccine development for emerging pathogens: Health Minister Mandaviya

The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective


Celanese showcases advanced medical materials solutions at Medtec China 2023
News | June 04, 2023

Celanese showcases advanced medical materials solutions at Medtec China 2023

elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont


Lonza acquires biotech firm Synaffix
News | June 02, 2023

Lonza acquires biotech firm Synaffix

Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology


Evonik launches next-generation peptide for biopharma applications
News | June 02, 2023

Evonik launches next-generation peptide for biopharma applications

One thousand times more soluble than L-cystine at neutral pH


Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options
Diagnostic Center | June 02, 2023

Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options

Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone


Laurus Labs to increase stake in ImmunoACT to 33.86%
News | June 01, 2023

Laurus Labs to increase stake in ImmunoACT to 33.86%

This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19


Glenmark sets GHG emission targets for FY2035
Sustainability | June 01, 2023

Glenmark sets GHG emission targets for FY2035

The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock